ShadowBuys
Sign inJoin for free

Rep. Jefferson Shreve sold Amgen (AMGN)

Rep. Jefferson Shreve (R-IN-6) · $15K–$50K · traded May 12, 2025

Transaction
Sold
Amount
$15K–$50K
Owner
Not stated
Traded
May 12, 2025
Disclosed
Jun 22, 2025
Days to disclose
41
Asset type
Stock
As filed
Amgen Inc. - Common Stock
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Shreve's tradesAll Congress trades in AMGN

Other trades in this filing

All of Shreve's trades →

Recent Congress trades in AMGN

Company context for AMGN

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. AMGNContract award·USAspending

    AMGN: Department of Health and Human Services contract award

    NPLATE ADMINISTRATION KIT DEVELOPMENT FOR THE TREATMENT OF APPROVED INDICATIONS, INCLUDING ACUTE RADIATION SYNDROME (ARS)

    First observed: Nov 8, 2026, 9:57 AM ESTEvent / period: Aug 28, 2023Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. AMGNFinancial report·SEC EDGAR

    AMGN: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 3, 2026, 6:37 PM ESTEvent / period: Sep 30, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. AMGNCompany announcement·SEC EDGAR

    AMGN: Financial results

    Filed 8-K for an event or period dated 2026-11-03. Financial results.

    Public: Nov 3, 2026, 4:05 PM ESTEvent / period: Nov 3, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.